Novartis research head visits International Vaccine Institute

Published: 2008-10-16 06:42:00

Updated: 2008-10-16 06:42:00

Dr. Paul Herrling, head of corporate Research, Novartis Inc., visited Dr. Cecil Czerkinsky, Deputy Director-General of International Vaccine Institute (IVI) on October 9, to discuss the promotion of vaccine science for humanity

Novartis will help the IVI accelerate the development and deployme...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK